Stock EW EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Edwards Lifesciences Corporation Share Price Swiss Exchange

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Delayed Swiss Exchange
Other stock markets
 09:05:35 27/06/2019 pm IST 		5-day change 1st Jan Change
60.6 CHF -1.45% Intraday chart for Edwards Lifesciences Corporation -.--% -.--%
01:13pm Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash MT
12:50pm Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln RE

Financials

Sales 2024 * 6.56B 5.91B 545B Sales 2025 * 7.2B 6.49B 599B Capitalization 52.36B 47.19B 4,352B
Net income 2024 * 1.61B 1.45B 134B Net income 2025 * 1.86B 1.68B 155B EV / Sales 2024 * 7.72 x
Net cash position 2024 * 1.7B 1.53B 141B Net cash position 2025 * 2.84B 2.56B 236B EV / Sales 2025 * 6.87 x
P/E ratio 2024 *
32.9 x
P/E ratio 2025 *
28.3 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.59%
More Fundamentals * Assessed data

Chart Edwards Lifesciences Corporation

Dynamic Chart

Latest news about Edwards Lifesciences Corporation

Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion MT
Some of the biggest splits in Corporate America RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril MT
Edwards Lifesciences hit with Meril's EU antitrust complaint RE
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability CI
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 MT
More news

Latest transcript on Edwards Lifesciences Corporation

Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation, Q1 2024 Earnings Call, Apr 25, 2024
More transcripts

Analyst Recommendations on Edwards Lifesciences Corporation

Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing MT
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing MT
More recommendations

Press releases Edwards Lifesciences Corporation

BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader PR
Edwards Lifesciences to Sell Critical Care to BD BU
Edwards Lifesciences : First Quarter 2024 Fact Sheet PU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability BU
Edwards Lifesciences: Q1 Earnings Snapshot AQ
More press releases

News in other languages on Edwards Lifesciences Corporation

EE.UU. - Valores a seguir en Wall Street (actualizado)
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street
STATI UNITI. - I titoli da tenere d'occhio a Wall Street
More news

Highs and lows

5 years
47.58
Extreme 47.5766666191
64.24
More quotes

Managers and Directors - Edwards Lifesciences Corporation

Managers TitleAgeSince
Bernard Zovighian CEO
 Chief Executive Officer 56 01/15/01
Scott Ullem DFI
 Director of Finance/CFO 57 01/14/01
Todd Brinton CTO
 Chief Tech/Sci/R&D Officer - 01/19/01
Members of the board TitleAgeSince
Leslie Heisz BRD
 Director/Board Member 63 05/16/05
Nicholas Valeriani CHM
 Chairman 67 13/14/13
Steven Loranger BRD
 Director/Board Member 72 16/16/16
More insiders

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
Advanced Medical Equipment & Technology
Calendar
04/06/2024 - William Blair Growth Stock Conference
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89 USD
Average target price
96.55 USD
Spread / Average Target
+11.12%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.01% 217B
DANAHER CORPORATION Stock Danaher Corporation
+11.01% 190B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+19.20% 143B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.79% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.18% 64.59B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.16% 48.45B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.20% 38.03B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.91% 35.6B
RESMED, INC. Stock ResMed, Inc.
+19.95% 30.31B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. EW Stock
  4. EW Stock